Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India · Delayed Price · Currency is INR 12.95
+0.40 (3.19%)
Oct 1, 2026, 3:12 PM IST
NSE:NIDAN Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 19.95 | 18.99 | 28.5 | 84.19 | 81.01 |
Cash & Short-Term Investments | 19.95 | 18.99 | 28.5 | 84.19 | 81.01 |
Cash Growth | 5.01% | -33.35% | -66.15% | 3.92% | 9.53% |
Accounts Receivable | 22.17 | 12.68 | 5.24 | 60.26 | 53.62 |
Other Receivables | 6.18 | 6.77 | 7.59 | 12.31 | 14.19 |
Receivables | 91.97 | 62.68 | 252.28 | 100.89 | 153.26 |
Inventory | 5.3 | 5.47 | 3.02 | 3.65 | 2.16 |
Prepaid Expenses | 0.55 | 1.15 | 0.19 | 0.48 | 0.35 |
Other Current Assets | 27.85 | 23.73 | 18.79 | 19.59 | 16.25 |
Total Current Assets | 145.62 | 112.02 | 302.78 | 208.81 | 253.03 |
Property, Plant & Equipment | 133.96 | 148.19 | 163.18 | 197.15 | 242.62 |
Long-Term Investments | 200 | 200 | - | - | - |
Other Intangible Assets | 16.66 | 16.65 | 16.69 | 16.78 | 0.12 |
Long-Term Deferred Tax Assets | 6.35 | 7.69 | 8.2 | 4.83 | 4.54 |
Other Long-Term Assets | 48.55 | 48.01 | 48.93 | 94.01 | 384.49 |
Total Assets | 839.95 | 829.41 | 825.51 | 844.02 | 884.79 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 7.74 | 9.63 | 7.3 | 2.06 | 11.49 |
Accrued Expenses | 14.12 | 15.12 | 13.32 | 5.84 | 4.98 |
Short-Term Debt | 72.07 | 69.36 | 73.66 | 48.89 | 87.09 |
Current Portion of Long-Term Debt | 3.22 | 2.8 | 7.75 | 12.66 | 11.68 |
Current Income Taxes Payable | 5.02 | 5.06 | 11.17 | 26.23 | 12.59 |
Other Current Liabilities | -0 | - | - | - | - |
Total Current Liabilities | 102.16 | 101.96 | 113.2 | 95.69 | 127.83 |
Long-Term Debt | 36.35 | 38.95 | 42.94 | 47.75 | 94.17 |
Pension & Post-Retirement Benefits | 3.91 | 5.93 | 5.65 | 4.52 | 0.39 |
Other Long-Term Liabilities | 0.64 | 0.74 | 1.66 | 1.67 | 3.4 |
Total Liabilities | 143.06 | 147.58 | 163.45 | 149.63 | 225.8 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 139 | 139 | 139 | 139 | 139 |
Additional Paid-In Capital | 459.05 | 459.05 | 459.05 | 459.05 | 459.05 |
Retained Earnings | 98.84 | 83.78 | 64.01 | 96.33 | 60.94 |
Shareholders' Equity | 696.89 | 681.83 | 662.06 | 694.38 | 658.99 |
Total Liabilities & Equity | 839.95 | 829.41 | 825.51 | 844.02 | 884.79 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 111.64 | 111.1 | 124.35 | 109.3 | 192.95 |
Net Cash (Debt) | -91.69 | -92.11 | -95.85 | -25.11 | -111.93 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -6.60 | -6.63 | -6.90 | -1.81 | -9.76 |
Filing Date Shares Outstanding | 13.9 | 13.9 | 13.9 | 13.9 | 13.02 |
Total Common Shares Outstanding | 13.9 | 13.9 | 13.9 | 13.9 | 13.02 |
Working Capital | 43.45 | 10.06 | 189.58 | 113.13 | 125.2 |
Book Value Per Share | 50.14 | 49.05 | 47.63 | 49.96 | 50.60 |
Tangible Book Value | 680.23 | 665.18 | 645.37 | 677.6 | 658.87 |
Tangible Book Value Per Share | 48.94 | 47.85 | 46.43 | 48.75 | 50.59 |
Buildings | 181.93 | 181.93 | 181.93 | 210.58 | 221.22 |
Machinery | 389.14 | 384.44 | 376.77 | 377.95 | 375.04 |
Construction In Progress | 1.51 | 1.51 | 0.35 | - | 38.14 |